NCT05064800 - PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

December 6, 2021

Study Completion Date

December 6, 2021

Conditions

Healthy Participants

Interventions

DRUG

Dabigatran

A single dose of Dabigatran on Day 1

DRUG

PF-07321332/ritonavir + Dabigatran

PF-07321332/ritonavir twice daily (BID) for Days 1 and 2 Single dose of Dabigatran on Day 2

DRUG

Ritonavir + Dabigatran

Ritonavir BID on Days 1 and 2 Single dose of Dabigatran on Day 2

Trial Locations (1)

Research Centers of America ( Hollywood ), Hollywood